Edgewise Therapeutics, Inc.’s EWTX share price has surged by 7.97%, which has investors questioning if this is right time to sell.

Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb are included in this Analyst Blog.

In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against other stocks ...

Market volatility has not dissuaded some insiders from making big share purchases. The most notable transactions came from ...

Penumbra Inc (NYSE: PEN ): Adam Elsesser, CEO and President, sold shares totaling approximately $4.5 million at prices ranging from $267.36 to $277.63 per share. Elsesser also exercised stock options ...

Shares of Edgewise Therapeutics EWTX plunged 47.7% in a week, likely due to safety concerns for its investigational candidate, EDG-7500, in patients with obstructive or nonobstructive hypertrophic ...

We recently published a list of 10 Unstoppable Stocks That Could Double Your Money. In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against other ...

In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against other unstoppable stocks that could double your money. Generating significant returns ...

Edgewise Therapeutics Inc. operates (NASDAQ:EWTX) as a clinical-stage biotech company that creates precise therapeutic solutions for uncommon and critical muscular disorders. The company currently ...

Fintel reports that on April 3, 2025, Scotiabank downgraded their outlook for Edgewise Therapeutics (NasdaqGS:EWTX) from Sector Outperform to Sector Perform. Analyst Price Forecast Suggests 258.92 ...